# Genotype-drive Study of Irinotecan-Cisplatin Combination for Advanced Gastric Cancer

> **NCT01444521** · PHASE2 · COMPLETED · sponsor: **Chinese Academy of Medical Sciences** · enrollment: 50 (actual)

## Conditions studied

- Gastric Cancer

## Interventions

- **DRUG:** irinotecan and cisplatin

## Key facts

- **NCT ID:** NCT01444521
- **Lead sponsor:** Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2014-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01444521

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01444521, "Genotype-drive Study of Irinotecan-Cisplatin Combination for Advanced Gastric Cancer". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT01444521. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*